title: [Postgastrectomy dumping treated with octreotide (Sandostatin)].
abstract: Somatostatin and the long acting somatostatin analogue Sandostatin have been shown to be effective in the management of dumping syndrome. We describe a patient with early dumping in whom this management provided total symptomatic relief. The doses was reduced from 50 micrograms to 12.5 micrograms s.c., t.i.d. At this dose clinical and biochemical parameters (blood pressure, pulse rate, packed cell volume, hematocrit, and blood glucose) were found to be within normal levels.
authors.affiliation: Gastroenterologisk afsnit, kirurgisk afdeling K, Bispebjerg Hospital, København.
authors.forename: T D
authors.initials: TD
authors.lastname: Møller
authors.forename: C U
authors.initials: CU
authors.lastname: Carlsen
mesh_terms: D000328:Adult; D004377:Dumping Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D015282:Octreotide / Q000008:administration & dosage*
chemical_list: D015282:Octreotide
vernacular_title: Postgastrektomibetinget dumping behandlet med octreotid (Sandostatin).